BI-836858 is a fully humanized IgG1 anti-CD33 monoclonal antibody. It is modified at the Fc fragment to enhance binding with FcgammaRIIIa (CD16). BI-836858 exhibits antibody-dependent cellular cytotoxicity (ADCC) activity and is utilized in research related to acute myeloid leukemia (AML).
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted